logo

Shariah compliance overview

Not Halal

Immunovant, Inc. (IMVT) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Immunovant, Inc.

Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody.

Immunovant, Inc. (IMVT) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
12.25%Limit 30%Pass
Interest-bearing securities and assets
20.32%Limit 30%Pass
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Immunovant, Inc. (IMVT). Current Akinda screening label: Not Halal.